Global Hypertension Market By Type (Primary Hypertension, Secondary Hypertension, Others), Measurement Categories (Normal Blood Pressure, Elevated Blood Pressure, Stage 1 Hypertension, Stage 2 Hypertension, Others), Treatment (Medication, Additional Therapy, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Hypertension Market
Global hypertension market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Rising prevalence of cardiovascular diseases worldwide and emerging markets are the factors responsible for the growth of this market.
Adoption of unhealthy life style drives the growth of hypertension market. However, continues clinical development for the treatment of hypertension, huge research and development investment leading to intense pipeline products and increased initiative taken by the pharmaceutical organization & government authorities to raise the awareness among the population will drive the hypertension market. But, large number of patent expiration may hamper the hypertension market.
Hypertension or elevated blood pressure which causes serious medical condition that significantly increases the risks of heart, brain, and kidney among other diseases. Blood pressure denoted as two numbers, that is systolic blood pressure which represents pressure in blood vessels when the heart contracts or beats and diastolic blood pressure which represents the pressure in the vessels when the heart rests between beats. The normal blood pressure is 120/80 mm Hg.
According to the WHO, an estimated 1.13 billion people worldwide have hypertension, most (two-thirds) living in low- and middle-income countries. One of the global targets for noncommunicable diseases is to reduce the prevalence of hypertension by 25% by 2025.
This hypertension market report provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Hypertension Market Scope and Market Size
Hypertension market is segmented on the basis of type, measurement categories, treatment, end-users and distribution channel.
- On the basis of type, the hypertension market is segmented into primary hypertension, secondary hypertension and others
- On the basis of measurement categories, the hypertension market is segmented into normal blood pressure, elevated blood pressure, stage 1 hypertension, stage 2 hypertension and others
- On the basis of treatment, the hypertension market is segmented into medication, additional therapy and others. Treatment by medication includes thiazide diuretics, ACE inhibitor, angiotensin II receptor blockers, calcium channel blockers, alpha blockers, beta blockers, alpha-beta blockers, aldosterone antagonists, renin inhibitors, vasodilators and others. treatment by additional therapy includes exercise, yoga, stress management and others
- On the basis of end-users, the hypertension market is segmented into hospitals, homecare, specialty clinics and others.
- On the basis of distribution channel, the hypertension market has also been segmented into hospital pharmacies, online pharmacies, retail pharmacies and others
Hypertension Market Country Level Analysis
Hypertension market is analysed and market size information is provided by country, type, measurement categories, treatment, end-users and distribution channel as referenced above.
The countries covered in the hypertension market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
- On geographical estimation, North America accounts the largest market share due to the increased R & D activities in the industry and higher healthcare expenditure in this region. Europe accounts to be second largest market share due to increased population with cardiovascular diseases, and availability of funds for research. Asia-Pacific is expected to account for the largest market share over coming years for the hypertension market due to increased prevalence of hypertension diseases and increasing geriatric population.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Hypertension market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Hypertension Market Share Analysis
Hypertension market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to hypertension market.
The major players covered in the hypertension market are Pfizer Inc., Amgen Inc., Cytokinetics, Inc., Hikma Pharmaceutical PLC., AbbVie Inc., Lupin Ltd., Wockhardt, Glenmark., Zydus Pharmaceutical Inc., Amneal pharmaceutical LLC., Accord Healthcare., Aurobindo Pharma, and Sun Pharmaceutical Industries Ltd., among others.
Customization Available: Global Hypertension Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.